WW- and SH3-domain interactions with epstein-barr virus LMP2A

Experimental Cell Research

Volumn 257, Issue 2, 2000, Pages 332-340

  Longnecker, Richard ^a   Merchant, Mark ^a   Brown, Melissa E ^b   Fruehling, Sara ^a   Bickford, James O ^b   Ikeda, Masato ^a   Harty, Ronald N ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; MEMBRANE PROTEIN; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

DNA VIRUSES; HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 0034660244     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4900     Document Type: Article

References (57)

1. Kieff E. Epstein-Barr virus and its replication. Fields B. N., Knipe D. M., Howley P. M. Fundamental Virology. 1996;1109-1162 Lippincott-Raven.
2. Longnecker R. Molecular biology of Epstein-Barr virus. McCaance Dennis. Human Tumor Viruses. 1998;133-172 Am. Soc. for Microbiol.
3. Rickinson A. B., Kieff E. Epstein-Barr virus. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;2397-2446 Lippincott-Raven, Philadelphia.
4. Liebowitz D. Epstein-Barr Pathogenesis. McCaance Dennis. Human Tumor Viruses. 1998;173-198 Am. Soc. for Microbiol.
5. Chen F., Zou J. Z., di Renzo L. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69:1995;3752-3758.
6. Miyashita E. M., Yang B., Babcock G. J., Thorley-Lawson D. A. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J. Virol. 71:1997;4882-4891.
7. Qu L., Rowe D. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J. Virol. 66:1992;3715-3724.
8. Tierney R. J., Steven N., Young L. S., Rickinson A. B. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:1994;7374-7385.
9. Sample J., Liebowitz D., Kieff E. Two related Epstein-Barr virus membrane proteins are encoded by separate genes. J. Virol. 63:1989;933-937.
10. Laux G., Perricaudet M., Farrell P. J. A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. EMBO J. 7:1988;769-774.
11. Laux G., Economou A., Farrell P. J. The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter region. J. Gen. Virol. 70:1989;3079-3084.
12. Longnecker R., Druker B., Roberts T. M., Kieff E. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J. Virol. 65:1991;3681-3692.
13. Longnecker R., Kieff E. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J. Virol. 64:1990;2319-2326.
14. Franken M., Annis B., Ali A. N., Wang F. 5′ Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio. J. Virol. 69:1995;8011-8019.
15. Campbell K. S. Signal transduction from the B cell antigen-receptor. Curr. Opin. Immunol. 11:1999;256-264.
16. Benschop R. J., Cambier J. C. B cell development: signal transduction by antigen receptors and their surrogates. Curr. Opin. Immunol. 11:1999;143-151.
17. Fruehling S., Swart R., Dolwick K. M., Kremmer E., Longnecker R. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J. Virol. 72:1998;7796-7806.
18. Fruehling S., Longnecker R. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology. 235:1997;241-251.
19. Miller C. L., Burkhardt A. L., Lee J. H., Stealey B., Longnecker R., Bolen J. B., Kieff E. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity. 2:1995;155-166.
20. Burkhardt A. L., Bolen J. B., Kieff E., Longnecker R. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J. Virol. 66:1992;5161-5167.
21. Berger C., Rothenberger S., Bachmann E., McQuain C., Nadal D., Knecht H. Sequence polymorphisms between latent membrane proteins LMP1 and LMP2A do not correlate in EBV-associated reactive and malignant lympho-proliferations. Int. J. Cancer. 81:1999;371-375.
22. Busson P., Edwards R. H., Tursz T., Raab Traub N. Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene. J. Gen. Virol. 76:1995;139-145.
23. Sudol M. From Src Homology domains to other signaling modules: proposal of the 'protein recognition code'. Oncogene. 17:1998;1469-1474.
24. Pawson T., Olivier P., Rozakis A. M., McGlade J., Henkemeyer M. Proteins with SH2 and SH3 domains couple receptor tyrosine kinases to intracellular signalling pathways. (Review). Philos. Trans. R. Soc. London Ser. B: Biol. Sci. 340:1993;279-285.
25. Bedford M. T., Chan D. C., Leder P. FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands. EMBO J. 16:1997;2376-2383.
26. Sudol M., Chen H. I., Bougeret C., Einbond A., Bork P. Characterization of a novel protein-binding module - the WW domain. FEBS Lett. 369:1995;67-71.
27. Sudol M. Structure and function of the WW domain. Prog. Biophys. Mol. Biol. 65:1996;113-132.
28. Kay B. K., Williamson M. P., Sudol M. The importance of being proline: The interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 14:1999;231-241.
29. Espanel X., Sudol M. A single point mutation in a group I WW domain shifts its specificity to that of group II WW domains. J. Biol. Chem. 274:1999;17284-17289.
30. Chen H. I., Sudol M. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc. Natl. Acad. Sci. USA. 92:1995;7819-7823.
31. Einbond A., Sudol M. Towards prediction of cognate complexes between the WW domain and proline-rich ligands. FEBS Lett. 384:1996;1-8.
32. Macias M. J., Hyvonen M., Baraldi E., Schultz J., Sudol M., Saraste M., Oschkinat H. Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide. Nature. 382:1996;646-649.
33. Chen H. I., Einbond A., Kwak S. J., Linn H., Koepf E., Peterson S., Kelly J. W., Sudol M. Characterization of the WW domain of human yes-associated protein and its polyproline-containing ligands. J. Biol. Chem. 272:1997;17070-17077.
34. Bork P., Sudol M. Trends Biochem. Sci. 19:1994;531-533.
35. Craven R. C., Harty R. N., Paragas J., Palese P., Wills J. W. Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras. J. Virol. 73:1999;3359-3365.
36. Garnier L., Wills J. W., Verderame M. F., Sudol M. WW domains and retrovirus budding. Nature. 381:1996;744-745.
37. Harty R. N., Paragas J., Sudol M., Palese P. A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J. Virol. 73:1999;2921-2929.
38. Sudol M. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene. 9:1994;2145-2152.
39. Sudol M., Bork P., Einbond A., Kastury K., Druck T., Negrini M., Huebner K., Lehman D. Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain. J. Biol. Chem. 270:1995;14733-14741.
40. Wood J. D., Yuan J., Margolis R. L., Colomer V., Duan K., Kushi J., Kaminsky Z., Kleiderlein J. J., Sharp A. H., Ross C. A. Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins. Mol. Cell. Neurosci. 11:1998;149-160.
41. Yamabhai M., Kay B. K. Examining the specificity of Src homology 3 domain - ligand interactions with alkaline phosphatase fusion proteins. Anal. Biochem. 247:1997;143-151.
42. Pleiman C. M., Abrams C., Gauen L. T., Bedzyk W., Jongstra J., Shaw A. S., Cambier J. C. Distinct p53/56lyn and p59fyn domains associate with nonphosphorylated and phosphorylated Ig-alpha. Proc. Natl. Acad. Sci. USA. 91:1994;4268-4272.
43. Stauffer T. P., Martenson C. H., Rider J. E., Kay B. K., Meyer T. Inhibition of Lyn function in mast cell activation by SH3 domain binding peptides. Biochemistry. 36:1997;9388-9394.
44. Ikeda M., Ikeda A., Longan L. C., Longnecker R. The Epstein-Barr virus (EBV) latent membrane protein 2A (LMP2A) PY motif recruits WW domain-containing ubiquitin-protein ligases. Virology. 268:2000;178-191.
45. Sparks A. B., Adey N. B., Quilliam L. A., Thorn J. M., Kay B. K. Screening phage-displayed random peptide libraries for SH3 ligands. Methods Enzymol. 255:1995;498-509.
46. Rentschler S., Linn H., Deininger K., Bedford M. T., Espanel X., Sudol M. The WW domain of dystrophin requires EF-hands region to interact with Beta-dystroglycan. Biol. Chem. 380:1999;431-442.
47. Fruehling S., Lee S. K., Herrold R., Frech B., Laux G., Kremmer E., Grasser F. A., Longnecker R. Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. J. Virol. 70:1996;6216-6226.
48. Miller C. L., Lee J. H., Kieff E., Longnecker R. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc. Natl. Acad. Sci. USA. 91:1994;772-776.
49. Bar-Sagi D., Rotin D., Batzer A., Mandiyan V., Schlessinger J. SH3 domains direct cellular localization of signaling molecules. Cell. 74:1993;83-91.
50. Lowenstein E. J., Daly R. J., Batzer A. G., Li W., Margolis B., Lammers R., Ullrich A., Skolnik E. Y., Bar-Sagi D., Schlessinger J. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell. 70:1992;431-442.
51. Pleiman C. M., Hertz W. M., Cambier J. C. Activation of phosphatidylinositol-3′ kinase by Src-family kinase SH3 binding to the p85 subunit. Science. 263:1994;1609-1612.
52. Pirozzi G., McConnell S. J., Uveges A. J., Carter J. M., Sparks A. B., Kay B. K., Fowlkes D. M. Identification of novel human WW domain-containing proteins by cloning of ligand targets. J. Biol. Chem. 272:1997;14611-14616.
53. Staub O., Dho S., Henry P., Correa J., Ishikawa T., McGlade J., Rotin D. WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle's syndrome. EMBO J. 15:1996;2371-2380.
54. Wang G., Yang J., Huibregtse J. M. Functional domains of the Rsp5 ubiquitin-protein ligase. Mol. Cell. Biol. 19:1999;342-352.
55. Chan D. C., Bedford M. T., Leder P. Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains. EMBO J. 15:1996;1045-1054.
56. Lu P. J., Zhou X. Z., Shen M., Lu K. P. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science. 283:1999;1325-1328.
57. Mohler P. J., Kreda S. M., Boucher R. C., Sudol M., Stutts M. J., Milgram S. L. Yes-associated protein 65 localizes p62 (c-Yes) to the apical compartment of airway epithelial cells. J. Cell Biol. 147:1999;879-890.